Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL793P is a human pseudogene corresponding to 7SL RNA, which is a component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for directing newly synthesized proteins to cellular membranes. Most 7SL RNA pseudogenes, including RN7SL793P, are non-functional and represent genomic copies that arose from the reverse transcription and integration of RNA into DNA, often being truncated and having structural diversity. They are generally not transcribed or translated; if transcribed, their RNA products do not have the canonical functions of their parent gene. RN7SL793P is therefore not considered a receptor, enzyme, transporter, or therapeutic target; it serves primarily as a genomic relic without established direct biological or disease relevance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 793, pseudogene (RN7SL793P).